-+ 0.00%
-+ 0.00%
-+ 0.00%

Rezolute Says It Had Encouraging FDA Meeting on Congenital Hyperinsulinism Drug Despite Missed Endpoint

Dow Jones·03/24/2026 11:53:00

Please log in to view news